Sales & Marketing News | pharmaphorum

News

Anavex sinks after pulling Alzheimer's filing in EU

Shares in Anavex Life Sciences lost more than a third of their value today after the company abandoned an EU filing for its Alzheimer's therapy.

News

ImmunityBio warned by FDA over 'misleading' Anktiva content

The FDA has sent a warning letter to ImmunityBio over "false and misleading" comments made by executive chair, billionaire Patrick Soon-Shiong.

News

Grifols board backs IPO for US business

Spanish plasma medicine specialist Grifols is planning to sell a minority stake in its US business, via an IPO, to help pay down its debt.

News

Patient sues Novartis, claiming data-tracking privacy breach

A cancer patient in the US has filed a class action lawsuit against Novartis in the US, claiming that the company shared her private health data.

News

After setback, Rhythm gets good news on Imcivree from FDA

Rhythm Pharma has secured the first approval in the US for a drug to treat hypothalamic obesity.

News

Appeal finds NICE must reconsider Alzheimer's drugs

Lilly and Eisai's bid to secure NHS coverage of their Alzheimer's therapies has entered a new phase, after an appeal of last year's rejection by NICE.

Anavex sinks after pulling Alzheimer's filing in EU

ImmunityBio warned by FDA over 'misleading' Anktiva content

Grifols board backs IPO for US business

Patient sues Novartis, claiming data-tracking privacy breach

After setback, Rhythm gets good news on Imcivree from FDA

Appeal finds NICE must reconsider Alzheimer's drugs

FDA issues warning letters to five unapproved GLP-1 websites

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks